ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,400,000 | -2.0% | 600,000 | +9.1% | 1.63% | -13.3% |
| Q3 2019 | $2,448,000 | +15.0% | 550,000 | 0.0% | 1.88% | +28.2% |
| Q2 2019 | $2,129,000 | -2.3% | 550,000 | -4.3% | 1.47% | -6.0% |
| Q1 2019 | $2,179,000 | +127.9% | 575,000 | +43.8% | 1.56% | +83.4% |
| Q4 2018 | $956,000 | -59.0% | 400,000 | +6.7% | 0.85% | -44.2% |
| Q3 2018 | $2,329,000 | +37.7% | 375,000 | 0.0% | 1.52% | +27.1% |
| Q2 2018 | $1,691,000 | +22.5% | 375,000 | +25.0% | 1.20% | +14.2% |
| Q1 2018 | $1,380,000 | -14.0% | 300,000 | -40.0% | 1.05% | -16.9% |
| Q4 2017 | $1,605,000 | – | 500,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |